Indian Journal of Urology Users online:1084  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
Year : 2010  |  Volume : 26  |  Issue : 1  |  Page : 82-91

Update on management of seminoma

Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, United Kingdom

Correspondence Address:
Alan Horwich
Department of Academic Radiotherapy, Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT
United Kingdom
Login to access the Email id

Source of Support: Institute of Cancer Research, the Bob Champion Cancer Trust and Cancer Research UK Section of Radiotherapy [CUK] grant number C46/A2131. NHS funding to the NIHR Biomedical Research Center,, Conflict of Interest: None

DOI: 10.4103/0970-1591.60451

Rights and Permissions

Testicular germ cell tumors and, in particular, seminomas are exquisitely radiation and chemotherapy-sensitive and most presentations are highly curable. In recent years the management focus has been on reducing late sequelae of treatment. For Stage I disease surveillance and adjuvant carboplatin, chemotherapy has become an option. The efficacy of combination chemotherapy has been established for advanced metastatic disease. Through a review of the available literature this article outlines the recent changes in the management of seminoma.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded413    
    Comments [Add]    
    Cited by others 3    

Recommend this journal